Single-dose pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase stimulator BAY 63-2521: an ascending-dose study in healthy male volunteers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples